ALS Advances Unite Patients and Pharma on Novel Targets, Biomarker Breakthroughs
ALS Advances Unite Patients and Pharma on Novel Targets, Biomarker Breakthroughs  
Podcast: BioSpace
Published On: Thu Feb 26 2026
Description: In this episode, you'll be listening to Indu Navar, CEO and founder of EverythingALS and Dr. Olga Uspenskaya, chief medical officer at VectorY Therapeutics. We'll be speaking about patient-pharma collaborations accelerating trials and hope, advances in ALS biology understanding and biomarker-driven endpoints.HostJennifer Smith-Parker, Director of Insights, BioSpaceGuests⁠Indu Navar⁠, CEO and Founder, EverythingALSDr. Olga Uspenskaya, Chief Medical Officer, VectorY TherapeuticsDisclaimer: The views expressed in this discussion by guests are their own and do not represent those of their organizations.